Divalproex Sodium Tablet, Film Coated, Extended Release
Product Images NDC 50090-7841

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 50090-7841). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (546b07bd 7dba 49c9 8caf 7914600d4d19 01)

Chemical structure diagram of divalproex sodium, showing the molecular arrangement including sodium (Na+) and hydrogen (H+) ions in its extended polymeric form.*

FDA Label Image

Image (546b07bd 7dba 49c9 8caf 7914600d4d19 02)

A line graph comparing the percentage reduction in CPS rate between Divalproex Sodium Delayed-Release Tablets and placebo across the percentage of patients. The y-axis shows percent reduction in CPS rate ranging from -100% (worsening) to 100% (improvement), with a line for no change at 0%. The x-axis represents the percentage of patients from 0 to 100. The solid line depicts the Divalproex Sodium Delayed-Release Tablets, and the dashed line represents placebo.*

FDA Label Image

Image (546b07bd 7dba 49c9 8caf 7914600d4d19 03)

A line graph depicting the percentage reduction in CPS rate among patients using high dose versus low dose divalproex sodium delayed-release tablets. The x-axis represents the percentage of patients, and the y-axis shows the percentage reduction in CPS rate, indicating patient improvement or worsening over the 0 to 100% range.*

FDA Label Image

Image (546b07bd 7dba 49c9 8caf 7914600d4d19 04)

A bar chart comparing the effect magnitude between placebo and divalproex sodium extended-release tablets. The y-axis shows a scale from 0 to 1.2, with the placebo bar reaching 0.6 and the divalproex sodium bar reaching 1.2. The chart includes a significance indicator with p=0.006.*

FDA Label Image

Logo (546b07bd 7dba 49c9 8caf 7914600d4d19 05)

FDA Label Image

Label Image (Lbl500907841)

Label for divalproex sodium 500 mg extended-release film-coated tablets by A-S Medication Solutions. The package contains 30 tablets and includes instructions to store at 68 to 77 degrees Fahrenheit and to use daily with food. The label references the product NDC 50090-7841.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.